Finance

Beta
Lists
REKA:TLV
Rekah Pharmaceutical Industry Ltd
ILA 1,111.00
+4.03%
(+43.00) 1D
Jun 3, 5:24:02 PM GMT+3  ·   ILA
All symbols
SymbolPriceChange% Change
Generating top insights for REKA...
Mkt. cap
128.03M
Avg. vol.
1.53K
Volume
0.00
52-wk high
ILA 1,383.00
52-wk low
ILA 1,044.00
EPS
-ILA 1.58
Shares outstanding
11.52M
No. of employees
390
Mkt. cap
128.03M
Avg. vol.
1.53K
Volume
0.00
52-wk high
ILA 1,383.00
52-wk low
ILA 1,044.00
EPS
-ILA 1.58
Shares outstanding
11.52M
No. of employees
390
News stories
From sources across the web
About Rekah Pharmaceutical Industry Ltd
CEO-
Employees390
Founded1947
Headquarters-
SectorPharmaceutical industry
Websiterekah.co.il
Previous reportsAll values in ILS
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in ILS
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
76.15M
72.86M
75.07M
76.91M
Cost of goods sold
56.46M
56.30M
58.07M
60.59M
Cost of revenue
56.46M
56.30M
58.07M
60.59M
Research and development expenses
1.10M
1.11M
1.09M
994.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18.43M
17.12M
18.42M
17.56M
Operating expense
19.66M
18.29M
19.88M
18.98M
Total operating expenses
76.12M
74.59M
77.94M
79.57M
Operating income
23.00K
-1.73M
-2.87M
-2.66M
Other non operating income
-
-
-
-773.00K
EBT including unusual items
-1.47M
-3.48M
-4.56M
-1.69M
EBT excluding unusual items
-1.30M
-3.63M
-4.26M
-5.23M
Income tax expense
944.00K
572.00K
767.00K
4.59M
Effective tax rate
-64.39%
-16.44%
-16.82%
-271.13%
Other operating expenses
128.00K
60.00K
367.00K
427.00K
Net income
-2.41M
-4.05M
-5.33M
-6.29M
Net profit margin
-3.16%
-5.56%
-7.09%
-8.17%
Earnings per share
-
-
-
-
Interest and investment income
575.00K
74.00K
69.00K
-
Interest expense
-1.89M
-2.07M
-1.34M
-1.46M
Net interest expenses
-1.32M
-2.00M
-1.27M
-1.46M
Depreciation and amortization charges
-
-
-
-
EBITDA
8.04M
6.04M
4.66M
2.98M
Gain or loss from assets sale
5.00K
111.00K
167.00K
-445.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer